Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BriaCell Therapeutics Corp. T.BCT

Alternate Symbol(s):  BCTX

BriaCell Therapeutics Corp is an immuno-oncology focused biotechnology company developing targeted and safe approaches for the management of cancer. BriaCell, in collaboration with Incyte Corp., is conducting a Phase I/IIa clinical trial of Bria-IMT, its lead candidate, in a Combination Study with Incyte drugs, INCMGA00012, and epacadostat, in advanced breast cancer. Additionally, it is developing Bria-OTS, off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing and is designed to produce a potent and selective immune response against the cancer of each patient eliminating the time, expense and complex manufacturing logistics associated with immunotherapies.


Stock Price Chart (TSX:BCT)

Fundamentals Snapshot (TSX:BCT)

Bullboard Posts (TSX:BCT)

RE:RE:BCTX To Quickly Regain $8/share

I think you're on the right track here with the 50 and 200DMA.  We now have a situation with both a falling 50 and 200. ...
dragshot - 1 day ago

$NIRV looking good

check out the newly listed $NIRV, sheldon also involved with his son, looks like a big winner in the making! https://ceo.ca/@newsfile...
theleak - May 18, 2022

RE:BCTX To Quickly Regain $8/share

Well, that did not turn out at all how I imagined it.  I was able to add at these low levels today.  Still think there is...
LondonInvest - May 12, 2022

BCTX To Quickly Regain $8/share

Short-tem, BCTX should quickly regain $8/share to keep the 50-DMA rising and above the 200-DMA.  Very bullish here.  Short...
LondonInvest - April 29, 2022

RE:BCTX Fast Track FDA Approval

Sell off on great news after a run-up on no news!? What's going on? -TIA
HomerAndCompany - April 14, 2022

BCTX Fast Track FDA Approval

Well this week's options trading isn't at all suspicious!  I am long so happy about great advancement for company on...
LondonInvest - April 13, 2022